VThunter
a database for single-cell screening of virus target cells in animal kingdom
Monk parakeet

Taxonomy: Cellular organisms; Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata; Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Sauropsida; Sauria; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Psittaciformes; Psittacidae; Myiopsitta,

Latin Name: Myiopsitta monachus

Tested tissues: PBMC,

Data set information
Project Date Technology Tissue Condition Cell PMID/DOI
Vthunter_0060 2021.04 iDrop PBMC Normal 1958 Link
Virus Virus Name GeneTop 5 cell types expressing viral receptor ordered by expression proportion
Influenza A virus
PBMC-Macrophage : 97.91% ;
PBMC-Platelets : 63.41% ;
PBMC-B cells : 58.70% ;
PBMC-Erythroid Progenitors : 58.33% ;
PBMC-Monocyte : 53.97% ;
PBMC-Macrophage : 27.41% ;
PBMC-B cells : 25.00% ;
PBMC-Erythroid Progenitors : 16.67% ;
PBMC-Platelets : 13.41% ;
PBMC-T cells : 11.43% ;
Simian rotavirus A strain RRV
PBMC-Macrophage : 97.72% ;
PBMC-T cells : 95.71% ;
PBMC-B cells : 93.48% ;
PBMC-Platelets : 86.59% ;
PBMC-Erythroid Progenitors : 66.67% ;
PBMC-Macrophage : 86.93% ;
PBMC-Platelets : 73.17% ;
PBMC-B cells : 56.52% ;
PBMC-Monocyte : 51.59% ;
PBMC-T cells : 51.43% ;
PBMC-Platelets : 68.29% ;
PBMC-Macrophage : 18.27% ;
PBMC-T cells : 12.86% ;
PBMC-B cells : 10.87% ;
PBMC-Erythroid Progenitors : 8.33% ;
PBMC-Platelets : 68.29% ;
PBMC-Macrophage : 19.42% ;
PBMC-T cells : 15.71% ;
PBMC-B cells : 14.13% ;
PBMC-Monocyte : 8.73% ;
PBMC-Macrophage : 18.91% ;
PBMC-Erythroid Progenitors : 16.67% ;
PBMC-Platelets : 12.20% ;
PBMC-Monocyte : 7.94% ;
PBMC-B cells : 7.61% ;
Venezuelan equine encephalitis virus
PBMC-B cells : 92.39% ;
PBMC-Macrophage : 92.20% ;
PBMC-T cells : 84.29% ;
PBMC-Platelets : 64.63% ;
PBMC-Erythroid Progenitors : 58.33% ;
Sindbis virus
PBMC-B cells : 92.39% ;
PBMC-Macrophage : 92.20% ;
PBMC-T cells : 84.29% ;
PBMC-Platelets : 64.63% ;
PBMC-Erythroid Progenitors : 58.33% ;
Classical swine fever virus
PBMC-B cells : 92.39% ;
PBMC-Macrophage : 92.20% ;
PBMC-T cells : 84.29% ;
PBMC-Platelets : 64.63% ;
PBMC-Erythroid Progenitors : 58.33% ;
Adeno-associated virus - 2
PBMC-B cells : 92.39% ;
PBMC-Macrophage : 92.20% ;
PBMC-T cells : 84.29% ;
PBMC-Platelets : 64.63% ;
PBMC-Erythroid Progenitors : 58.33% ;
PBMC-Macrophage : 86.93% ;
PBMC-Platelets : 73.17% ;
PBMC-B cells : 56.52% ;
PBMC-Monocyte : 51.59% ;
PBMC-T cells : 51.43% ;
PBMC-Macrophage : 20.88% ;
PBMC-Erythroid Progenitors : 16.67% ;
PBMC-T cells : 12.86% ;
PBMC-B cells : 9.78% ;
PBMC-Platelets : 7.32% ;
Adeno-associated virus 9
PBMC-B cells : 92.39% ;
PBMC-Macrophage : 92.20% ;
PBMC-T cells : 84.29% ;
PBMC-Platelets : 64.63% ;
PBMC-Erythroid Progenitors : 58.33% ;
Adeno-associated virus - 8
PBMC-B cells : 92.39% ;
PBMC-Macrophage : 92.20% ;
PBMC-T cells : 84.29% ;
PBMC-Platelets : 64.63% ;
PBMC-Erythroid Progenitors : 58.33% ;
Adeno-associated virus - 3
PBMC-B cells : 92.39% ;
PBMC-Macrophage : 92.20% ;
PBMC-T cells : 84.29% ;
PBMC-Platelets : 64.63% ;
PBMC-Erythroid Progenitors : 58.33% ;
Dengue virus
PBMC-B cells : 92.39% ;
PBMC-Macrophage : 92.20% ;
PBMC-T cells : 84.29% ;
PBMC-Platelets : 64.63% ;
PBMC-Erythroid Progenitors : 58.33% ;
PBMC-Macrophage : 16.94% ;
PBMC-T cells : 2.86% ;
PBMC-Platelets : 1.22% ;
PBMC-B cells : 1.09% ;
PBMC-Monocyte : 0.79% ;
PBMC-Erythroid Progenitors : 8.33% ;
PBMC-B cells : 2.17% ;
PBMC-Macrophage : 2.16% ;
PBMC-T cells : 1.43% ;
PBMC-Monocyte : 0.00% ;
Echovirus E1
PBMC-Macrophage : 86.93% ;
PBMC-Platelets : 73.17% ;
PBMC-B cells : 56.52% ;
PBMC-Monocyte : 51.59% ;
PBMC-T cells : 51.43% ;
PBMC-Platelets : 68.29% ;
PBMC-Macrophage : 19.42% ;
PBMC-T cells : 15.71% ;
PBMC-B cells : 14.13% ;
PBMC-Monocyte : 8.73% ;
Human betaherpesvirus 5
PBMC-Macrophage : 86.93% ;
PBMC-Platelets : 73.17% ;
PBMC-B cells : 56.52% ;
PBMC-Monocyte : 51.59% ;
PBMC-T cells : 51.43% ;
PBMC-Platelets : 68.29% ;
PBMC-Macrophage : 18.27% ;
PBMC-T cells : 12.86% ;
PBMC-B cells : 10.87% ;
PBMC-Erythroid Progenitors : 8.33% ;
PBMC-Macrophage : 18.91% ;
PBMC-Erythroid Progenitors : 16.67% ;
PBMC-Platelets : 12.20% ;
PBMC-Monocyte : 7.94% ;
PBMC-B cells : 7.61% ;
Human rotavirus strain WA
PBMC-Macrophage : 86.93% ;
PBMC-Platelets : 73.17% ;
PBMC-B cells : 56.52% ;
PBMC-Monocyte : 51.59% ;
PBMC-T cells : 51.43% ;
PBMC-Platelets : 68.29% ;
PBMC-Macrophage : 19.42% ;
PBMC-T cells : 15.71% ;
PBMC-B cells : 14.13% ;
PBMC-Monocyte : 8.73% ;
Human gammaherpesvirus 4
PBMC-Macrophage : 86.93% ;
PBMC-Platelets : 73.17% ;
PBMC-B cells : 56.52% ;
PBMC-Monocyte : 51.59% ;
PBMC-T cells : 51.43% ;
PBMC-B cells : 1.09% ;
PBMC-Macrophage : 0.38% ;
PBMC-Monocyte : 0.00% ;
PBMC-Platelets : 0.00% ;
PBMC-T cells : 0.00% ;
Foot-and-mouth disease virus
PBMC-Macrophage : 86.93% ;
PBMC-Platelets : 73.17% ;
PBMC-B cells : 56.52% ;
PBMC-Monocyte : 51.59% ;
PBMC-T cells : 51.43% ;
PBMC-Platelets : 68.29% ;
PBMC-Macrophage : 18.27% ;
PBMC-T cells : 12.86% ;
PBMC-B cells : 10.87% ;
PBMC-Erythroid Progenitors : 8.33% ;
PBMC-Macrophage : 18.91% ;
PBMC-Erythroid Progenitors : 16.67% ;
PBMC-Platelets : 12.20% ;
PBMC-Monocyte : 7.94% ;
PBMC-B cells : 7.61% ;
PBMC-Monocyte : 1.59% ;
PBMC-Platelets : 1.22% ;
PBMC-B cells : 1.09% ;
PBMC-Macrophage : 0.76% ;
PBMC-T cells : 0.00% ;
Human parvovirus B19
PBMC-Macrophage : 86.93% ;
PBMC-Platelets : 73.17% ;
PBMC-B cells : 56.52% ;
PBMC-Monocyte : 51.59% ;
PBMC-T cells : 51.43% ;
Echovirus E8
PBMC-Macrophage : 86.93% ;
PBMC-Platelets : 73.17% ;
PBMC-B cells : 56.52% ;
PBMC-Monocyte : 51.59% ;
PBMC-T cells : 51.43% ;
PBMC-Platelets : 68.29% ;
PBMC-Macrophage : 19.42% ;
PBMC-T cells : 15.71% ;
PBMC-B cells : 14.13% ;
PBMC-Monocyte : 8.73% ;
Human metapneumovirus
PBMC-Macrophage : 86.93% ;
PBMC-Platelets : 73.17% ;
PBMC-B cells : 56.52% ;
PBMC-Monocyte : 51.59% ;
PBMC-T cells : 51.43% ;
Equid alphaherpesvirus 1
PBMC-Macrophage : 86.93% ;
PBMC-Platelets : 73.17% ;
PBMC-B cells : 56.52% ;
PBMC-Monocyte : 51.59% ;
PBMC-T cells : 51.43% ;
PBMC-Macrophage : 72.59% ;
PBMC-T cells : 57.14% ;
PBMC-B cells : 48.91% ;
PBMC-Platelets : 34.15% ;
PBMC-Monocyte : 25.40% ;
Mammalian orthoreovirus
PBMC-Macrophage : 86.93% ;
PBMC-Platelets : 73.17% ;
PBMC-B cells : 56.52% ;
PBMC-Monocyte : 51.59% ;
PBMC-T cells : 51.43% ;
Chikungunya virus
PBMC-Macrophage : 83.95% ;
PBMC-Platelets : 59.76% ;
PBMC-T cells : 57.14% ;
PBMC-B cells : 56.52% ;
PBMC-Monocyte : 47.62% ;
Hepacivirus C
PBMC-T cells : 74.29% ;
PBMC-Macrophage : 64.09% ;
PBMC-B cells : 45.65% ;
PBMC-Platelets : 29.27% ;
PBMC-Erythroid Progenitors : 25.00% ;
PBMC-Erythroid Progenitors : 66.67% ;
PBMC-B cells : 34.78% ;
PBMC-T cells : 17.14% ;
PBMC-Macrophage : 13.77% ;
PBMC-Platelets : 10.98% ;
PBMC-Macrophage : 14.47% ;
PBMC-Platelets : 8.54% ;
PBMC-B cells : 2.17% ;
PBMC-Monocyte : 1.59% ;
PBMC-T cells : 1.43% ;
PBMC-Erythroid Progenitors : 8.33% ;
PBMC-B cells : 2.17% ;
PBMC-Macrophage : 2.16% ;
PBMC-T cells : 1.43% ;
PBMC-Monocyte : 0.00% ;
PBMC-Platelets : 4.88% ;
PBMC-Macrophage : 4.31% ;
PBMC-T cells : 1.43% ;
PBMC-B cells : 1.09% ;
PBMC-Monocyte : 0.79% ;
PBMC-Macrophage : 0.32% ;
PBMC-Erythroid Progenitors : 0.00% ;
PBMC-Monocyte : 0.00% ;
PBMC-Platelets : 0.00% ;
PBMC-B cells : 0.00% ;
Bovine leukemia virus
PBMC-Macrophage : 74.24% ;
PBMC-B cells : 44.57% ;
PBMC-Monocyte : 34.92% ;
PBMC-Platelets : 31.71% ;
PBMC-T cells : 27.14% ;
Human immunodeficiency virus 1
PBMC-B cells : 73.91% ;
PBMC-T cells : 68.57% ;
PBMC-Platelets : 56.10% ;
PBMC-Macrophage : 53.17% ;
PBMC-Erythroid Progenitors : 41.67% ;
PBMC-T cells : 15.71% ;
PBMC-Platelets : 2.44% ;
PBMC-B cells : 1.09% ;
PBMC-Macrophage : 0.95% ;
PBMC-Monocyte : 0.00% ;
Human immunodeficiency virus 2
PBMC-B cells : 73.91% ;
PBMC-T cells : 68.57% ;
PBMC-Platelets : 56.10% ;
PBMC-Macrophage : 53.17% ;
PBMC-Erythroid Progenitors : 41.67% ;
PBMC-T cells : 15.71% ;
PBMC-Platelets : 2.44% ;
PBMC-B cells : 1.09% ;
PBMC-Macrophage : 0.95% ;
PBMC-Erythroid Progenitors : 0.00% ;
Feline immunodeficiency virus
PBMC-B cells : 73.91% ;
PBMC-T cells : 68.57% ;
PBMC-Platelets : 56.10% ;
PBMC-Macrophage : 53.17% ;
PBMC-Erythroid Progenitors : 41.67% ;
PBMC-B cells : 1.09% ;
PBMC-Macrophage : 0.25% ;
PBMC-Erythroid Progenitors : 0.00% ;
PBMC-Monocyte : 0.00% ;
PBMC-Platelets : 0.00% ;
Lassa mammarenavirus
PBMC-Macrophage : 70.75% ;
PBMC-Platelets : 34.15% ;
PBMC-T cells : 28.57% ;
PBMC-Monocyte : 26.19% ;
PBMC-B cells : 25.00% ;
PBMC-Macrophage : 16.94% ;
PBMC-T cells : 2.86% ;
PBMC-Platelets : 1.22% ;
PBMC-B cells : 1.09% ;
PBMC-Monocyte : 0.79% ;
PBMC-Macrophage : 15.23% ;
PBMC-Monocyte : 1.59% ;
PBMC-T cells : 1.43% ;
PBMC-Erythroid Progenitors : 0.00% ;
PBMC-Platelets : 0.00% ;
Hantaan orthohantavirus
PBMC-Platelets : 68.29% ;
PBMC-Macrophage : 18.27% ;
PBMC-T cells : 12.86% ;
PBMC-B cells : 10.87% ;
PBMC-Erythroid Progenitors : 8.33% ;
West Nile virus
PBMC-Platelets : 68.29% ;
PBMC-Macrophage : 18.27% ;
PBMC-T cells : 12.86% ;
PBMC-B cells : 10.87% ;
PBMC-Erythroid Progenitors : 8.33% ;
PBMC-Macrophage : 18.91% ;
PBMC-Erythroid Progenitors : 16.67% ;
PBMC-Platelets : 12.20% ;
PBMC-Monocyte : 7.94% ;
PBMC-B cells : 7.61% ;
Human gammaherpesvirus 8
PBMC-Platelets : 68.29% ;
PBMC-Macrophage : 18.27% ;
PBMC-T cells : 12.86% ;
PBMC-B cells : 10.87% ;
PBMC-Erythroid Progenitors : 8.33% ;
PBMC-Macrophage : 18.91% ;
PBMC-Erythroid Progenitors : 16.67% ;
PBMC-Platelets : 12.20% ;
PBMC-Monocyte : 7.94% ;
PBMC-B cells : 7.61% ;
PBMC-Macrophage : 0.19% ;
PBMC-Monocyte : 0.00% ;
PBMC-Platelets : 0.00% ;
PBMC-B cells : 0.00% ;
PBMC-T cells : 0.00% ;
Coxsackievirus A9
PBMC-Platelets : 68.29% ;
PBMC-Macrophage : 18.27% ;
PBMC-T cells : 12.86% ;
PBMC-B cells : 10.87% ;
PBMC-Erythroid Progenitors : 8.33% ;
PBMC-Macrophage : 18.91% ;
PBMC-Erythroid Progenitors : 16.67% ;
PBMC-Platelets : 12.20% ;
PBMC-Monocyte : 7.94% ;
PBMC-B cells : 7.61% ;
PBMC-Monocyte : 1.59% ;
PBMC-Platelets : 1.22% ;
PBMC-B cells : 1.09% ;
PBMC-Macrophage : 0.76% ;
PBMC-Erythroid Progenitors : 0.00% ;
Human parechovirus 1
PBMC-Platelets : 68.29% ;
PBMC-Macrophage : 18.27% ;
PBMC-T cells : 12.86% ;
PBMC-B cells : 10.87% ;
PBMC-Erythroid Progenitors : 8.33% ;
PBMC-Macrophage : 18.91% ;
PBMC-Erythroid Progenitors : 16.67% ;
PBMC-Platelets : 12.20% ;
PBMC-Monocyte : 7.94% ;
PBMC-B cells : 7.61% ;
Canine parvovirus
PBMC-Erythroid Progenitors : 66.67% ;
PBMC-B cells : 34.78% ;
PBMC-T cells : 17.14% ;
PBMC-Macrophage : 13.77% ;
PBMC-Platelets : 10.98% ;
Guanarito mammarenavirus
PBMC-Erythroid Progenitors : 66.67% ;
PBMC-B cells : 34.78% ;
PBMC-T cells : 17.14% ;
PBMC-Macrophage : 13.77% ;
PBMC-Platelets : 10.98% ;
Feline panleukopenia virus
PBMC-Erythroid Progenitors : 66.67% ;
PBMC-B cells : 34.78% ;
PBMC-T cells : 17.14% ;
PBMC-Macrophage : 13.77% ;
PBMC-Platelets : 10.98% ;
Mouse mammary tumor virus
PBMC-Erythroid Progenitors : 66.67% ;
PBMC-B cells : 34.78% ;
PBMC-T cells : 17.14% ;
PBMC-Macrophage : 13.77% ;
PBMC-Platelets : 10.98% ;
Machupo mammarenavirus
PBMC-Erythroid Progenitors : 66.67% ;
PBMC-B cells : 34.78% ;
PBMC-T cells : 17.14% ;
PBMC-Macrophage : 13.77% ;
PBMC-Platelets : 10.98% ;
Argentinian mammarenavirus
PBMC-Erythroid Progenitors : 66.67% ;
PBMC-B cells : 34.78% ;
PBMC-T cells : 17.14% ;
PBMC-Macrophage : 13.77% ;
PBMC-Platelets : 10.98% ;
Severe acute respiratory syndrome coronavirus 2
PBMC-Macrophage : 62.88% ;
PBMC-T cells : 14.29% ;
PBMC-Monocyte : 10.32% ;
PBMC-Erythroid Progenitors : 8.33% ;
PBMC-Platelets : 6.10% ;
PBMC-Macrophage : 14.47% ;
PBMC-Platelets : 8.54% ;
PBMC-B cells : 2.17% ;
PBMC-Monocyte : 1.59% ;
PBMC-T cells : 1.43% ;
Enterovirus A71
PBMC-T cells : 48.57% ;
PBMC-Macrophage : 45.94% ;
PBMC-Monocyte : 31.75% ;
PBMC-Platelets : 24.39% ;
PBMC-B cells : 22.83% ;
PBMC-Macrophage : 47.27% ;
PBMC-T cells : 15.71% ;
PBMC-B cells : 10.87% ;
PBMC-Platelets : 6.10% ;
PBMC-Monocyte : 5.56% ;
Coxsackievirus A16
PBMC-Macrophage : 47.27% ;
PBMC-T cells : 15.71% ;
PBMC-B cells : 10.87% ;
PBMC-Platelets : 6.10% ;
PBMC-Monocyte : 5.56% ;
Human papillomavirus type 16
PBMC-Macrophage : 45.05% ;
PBMC-B cells : 33.70% ;
PBMC-Platelets : 32.93% ;
PBMC-T cells : 27.14% ;
PBMC-Monocyte : 16.67% ;
PBMC-Platelets : 31.71% ;
PBMC-Macrophage : 10.60% ;
PBMC-B cells : 9.78% ;
PBMC-Monocyte : 6.35% ;
PBMC-T cells : 5.71% ;
Porcine reproductive and respiratory syndrome virus
PBMC-Macrophage : 45.05% ;
PBMC-B cells : 33.70% ;
PBMC-Platelets : 32.93% ;
PBMC-T cells : 27.14% ;
PBMC-Monocyte : 16.67% ;
PBMC-Macrophage : 2.79% ;
PBMC-Platelets : 1.22% ;
PBMC-Erythroid Progenitors : 0.00% ;
PBMC-Monocyte : 0.00% ;
PBMC-B cells : 0.00% ;
Japanese encephalitis virus
PBMC-Platelets : 30.49% ;
PBMC-B cells : 7.61% ;
PBMC-T cells : 7.14% ;
PBMC-Macrophage : 5.96% ;
PBMC-Monocyte : 2.38% ;
Ebola virus
PBMC-Macrophage : 29.12% ;
PBMC-Platelets : 12.20% ;
PBMC-B cells : 8.70% ;
PBMC-Monocyte : 7.94% ;
PBMC-T cells : 2.86% ;
PBMC-Macrophage : 16.94% ;
PBMC-T cells : 2.86% ;
PBMC-Platelets : 1.22% ;
PBMC-B cells : 1.09% ;
PBMC-Monocyte : 0.79% ;
PBMC-Macrophage : 6.79% ;
PBMC-Platelets : 6.10% ;
PBMC-T cells : 2.86% ;
PBMC-B cells : 2.17% ;
PBMC-Erythroid Progenitors : 0.00% ;
Vesicular stomatitis virus
PBMC-Macrophage : 27.41% ;
PBMC-B cells : 25.00% ;
PBMC-Erythroid Progenitors : 16.67% ;
PBMC-Platelets : 13.41% ;
PBMC-T cells : 11.43% ;
Coxsackievirus B1
PBMC-Macrophage : 18.91% ;
PBMC-Erythroid Progenitors : 16.67% ;
PBMC-Platelets : 12.20% ;
PBMC-Monocyte : 7.94% ;
PBMC-B cells : 7.61% ;
PBMC-T cells : 2.86% ;
PBMC-Macrophage : 1.90% ;
PBMC-Monocyte : 0.79% ;
PBMC-B cells : 0.00% ;
PBMC-Erythroid Progenitors : 0.00% ;
PBMC-Monocyte : 1.59% ;
PBMC-Platelets : 1.22% ;
PBMC-B cells : 1.09% ;
PBMC-Macrophage : 0.76% ;
PBMC-T cells : 0.00% ;
Human mastadenovirus C
PBMC-Macrophage : 18.91% ;
PBMC-Erythroid Progenitors : 16.67% ;
PBMC-Platelets : 12.20% ;
PBMC-Monocyte : 7.94% ;
PBMC-B cells : 7.61% ;
PBMC-T cells : 2.86% ;
PBMC-Macrophage : 1.90% ;
PBMC-Monocyte : 0.79% ;
PBMC-B cells : 0.00% ;
PBMC-Erythroid Progenitors : 0.00% ;
PBMC-Macrophage : 0.38% ;
PBMC-Erythroid Progenitors : 0.00% ;
PBMC-Monocyte : 0.00% ;
PBMC-Platelets : 0.00% ;
PBMC-B cells : 0.00% ;
Human alphaherpesvirus 1
PBMC-Macrophage : 18.91% ;
PBMC-Erythroid Progenitors : 16.67% ;
PBMC-Platelets : 12.20% ;
PBMC-Monocyte : 7.94% ;
PBMC-B cells : 7.61% ;
PBMC-B cells : 2.17% ;
PBMC-Macrophage : 1.08% ;
PBMC-T cells : 0.00% ;
PBMC-Erythroid Progenitors : 0.00% ;
PBMC-Monocyte : 0.00% ;
PBMC-Monocyte : 1.59% ;
PBMC-Platelets : 1.22% ;
PBMC-B cells : 1.09% ;
PBMC-Macrophage : 0.76% ;
PBMC-Erythroid Progenitors : 0.00% ;
Human mastadenovirus B
PBMC-Macrophage : 17.45% ;
PBMC-Platelets : 3.66% ;
PBMC-B cells : 1.09% ;
PBMC-Monocyte : 0.79% ;
PBMC-T cells : 0.00% ;
PBMC-Macrophage : 3.87% ;
PBMC-T cells : 2.86% ;
PBMC-Platelets : 1.22% ;
PBMC-B cells : 1.09% ;
PBMC-Monocyte : 0.79% ;
Zika virus
PBMC-Macrophage : 16.94% ;
PBMC-T cells : 2.86% ;
PBMC-Platelets : 1.22% ;
PBMC-B cells : 1.09% ;
PBMC-Monocyte : 0.79% ;
Marburg marburgvirus
PBMC-Macrophage : 16.94% ;
PBMC-T cells : 2.86% ;
PBMC-Platelets : 1.22% ;
PBMC-B cells : 1.09% ;
PBMC-Monocyte : 0.79% ;
PBMC-Macrophage : 6.79% ;
PBMC-Platelets : 6.10% ;
PBMC-T cells : 2.86% ;
PBMC-B cells : 2.17% ;
PBMC-Erythroid Progenitors : 0.00% ;
Lymphocytic choriomeningitis mammarenavirus
PBMC-Macrophage : 16.94% ;
PBMC-T cells : 2.86% ;
PBMC-Platelets : 1.22% ;
PBMC-B cells : 1.09% ;
PBMC-Monocyte : 0.79% ;
PBMC-Macrophage : 15.23% ;
PBMC-Monocyte : 1.59% ;
PBMC-T cells : 1.43% ;
PBMC-Platelets : 0.00% ;
PBMC-B cells : 0.00% ;
Simian sarcoma-associated virus
PBMC-Erythroid Progenitors : 16.67% ;
PBMC-T cells : 14.29% ;
PBMC-Macrophage : 11.23% ;
PBMC-Platelets : 8.54% ;
PBMC-B cells : 7.61% ;
Feline leukemia virus strain B/lambda-B1
PBMC-Erythroid Progenitors : 16.67% ;
PBMC-T cells : 14.29% ;
PBMC-Macrophage : 11.23% ;
PBMC-Platelets : 8.54% ;
PBMC-B cells : 7.61% ;
PBMC-Macrophage : 9.33% ;
PBMC-B cells : 6.52% ;
PBMC-Platelets : 3.66% ;
PBMC-T cells : 2.86% ;
PBMC-Monocyte : 0.79% ;
Andes orthohantavirus
PBMC-Erythroid Progenitors : 16.67% ;
PBMC-Platelets : 1.22% ;
PBMC-B cells : 0.00% ;
PBMC-T cells : 0.00% ;
PBMC-Macrophage : 0.00% ;
Gibbon ape leukemia virus
PBMC-Erythroid Progenitors : 16.67% ;
PBMC-T cells : 14.29% ;
PBMC-Macrophage : 11.23% ;
PBMC-Platelets : 8.54% ;
PBMC-B cells : 7.61% ;
PBMC-Macrophage : 9.33% ;
PBMC-B cells : 6.52% ;
PBMC-Platelets : 3.66% ;
PBMC-T cells : 2.86% ;
PBMC-Monocyte : 0.79% ;
Sin Nombre orthohantavirus
PBMC-Erythroid Progenitors : 16.67% ;
PBMC-Platelets : 1.22% ;
PBMC-Monocyte : 0.00% ;
PBMC-B cells : 0.00% ;
PBMC-T cells : 0.00% ;
Polytropic murine leukemia virus
PBMC-Macrophage : 16.43% ;
PBMC-B cells : 9.78% ;
PBMC-Erythroid Progenitors : 8.33% ;
PBMC-T cells : 7.14% ;
PBMC-Platelets : 4.88% ;
Xenotropic murine leukemia virus
PBMC-Macrophage : 16.43% ;
PBMC-B cells : 9.78% ;
PBMC-Erythroid Progenitors : 8.33% ;
PBMC-T cells : 7.14% ;
PBMC-Platelets : 4.88% ;
Simian immunodeficiency virus
PBMC-T cells : 15.71% ;
PBMC-Platelets : 2.44% ;
PBMC-B cells : 1.09% ;
PBMC-Macrophage : 0.95% ;
PBMC-Monocyte : 0.00% ;
Human betaherpesvirus 7
PBMC-T cells : 15.71% ;
PBMC-Platelets : 2.44% ;
PBMC-B cells : 1.09% ;
PBMC-Macrophage : 0.95% ;
PBMC-Erythroid Progenitors : 0.00% ;
Oliveros mammarenavirus
PBMC-Macrophage : 15.23% ;
PBMC-Monocyte : 1.59% ;
PBMC-T cells : 1.43% ;
PBMC-B cells : 0.00% ;
PBMC-Erythroid Progenitors : 0.00% ;
Latino mammarenavirus
PBMC-Macrophage : 15.23% ;
PBMC-Monocyte : 1.59% ;
PBMC-T cells : 1.43% ;
PBMC-Erythroid Progenitors : 0.00% ;
PBMC-Platelets : 0.00% ;
Human alphaherpesvirus 3
PBMC-Macrophage : 14.02% ;
PBMC-T cells : 11.43% ;
PBMC-Monocyte : 5.56% ;
PBMC-B cells : 4.35% ;
PBMC-Platelets : 3.66% ;
Varicella Zoster Virus
PBMC-Macrophage : 14.02% ;
PBMC-T cells : 11.43% ;
PBMC-Monocyte : 5.56% ;
PBMC-B cells : 4.35% ;
PBMC-Platelets : 3.66% ;
Feline leukemia virus strain C/FA27
PBMC-Platelets : 12.20% ;
PBMC-Macrophage : 9.77% ;
PBMC-T cells : 8.57% ;
PBMC-B cells : 5.43% ;
PBMC-Monocyte : 2.38% ;
Respiratory syncytial virus
PBMC-T cells : 11.43% ;
PBMC-Platelets : 6.10% ;
PBMC-Macrophage : 1.65% ;
PBMC-Monocyte : 0.79% ;
PBMC-Erythroid Progenitors : 0.00% ;
Amphotropic murine leukemia virus
PBMC-Macrophage : 9.33% ;
PBMC-B cells : 6.52% ;
PBMC-Platelets : 3.66% ;
PBMC-T cells : 2.86% ;
PBMC-Monocyte : 0.79% ;
Coxsackievirus A10
PBMC-Erythroid Progenitors : 8.33% ;
PBMC-Monocyte : 3.97% ;
PBMC-Macrophage : 3.24% ;
PBMC-T cells : 1.43% ;
PBMC-B cells : 1.09% ;
Middle East respiratory syndrome-related coronavirus
PBMC-Macrophage : 8.31% ;
PBMC-Platelets : 4.88% ;
PBMC-Monocyte : 1.59% ;
PBMC-T cells : 1.43% ;
PBMC-B cells : 1.09% ;
Phocine morbillivirus
PBMC-B cells : 4.35% ;
PBMC-Platelets : 2.44% ;
PBMC-T cells : 1.43% ;
PBMC-Macrophage : 0.19% ;
PBMC-Erythroid Progenitors : 0.00% ;
Canine morbillivirus
PBMC-B cells : 4.35% ;
PBMC-Platelets : 2.44% ;
PBMC-T cells : 1.43% ;
PBMC-Macrophage : 0.19% ;
PBMC-Erythroid Progenitors : 0.00% ;
Rinderpest morbillivirus
PBMC-B cells : 4.35% ;
PBMC-Platelets : 2.44% ;
PBMC-T cells : 1.43% ;
PBMC-Macrophage : 0.19% ;
PBMC-Monocyte : 0.00% ;
Measles morbillivirus
PBMC-B cells : 4.35% ;
PBMC-Platelets : 2.44% ;
PBMC-T cells : 1.43% ;
PBMC-Macrophage : 0.19% ;
PBMC-Erythroid Progenitors : 0.00% ;
Human mastadenovirus A
PBMC-T cells : 2.86% ;
PBMC-Macrophage : 1.90% ;
PBMC-Monocyte : 0.79% ;
PBMC-Erythroid Progenitors : 0.00% ;
PBMC-Platelets : 0.00% ;
Human mastadenovirus D
PBMC-T cells : 2.86% ;
PBMC-Macrophage : 1.90% ;
PBMC-Monocyte : 0.79% ;
PBMC-Erythroid Progenitors : 0.00% ;
PBMC-Platelets : 0.00% ;
Coxsackievirus B3
PBMC-T cells : 2.86% ;
PBMC-Macrophage : 1.90% ;
PBMC-Monocyte : 0.79% ;
PBMC-Erythroid Progenitors : 0.00% ;
PBMC-Platelets : 0.00% ;
Coxsackievirus B2
PBMC-T cells : 2.86% ;
PBMC-Macrophage : 1.90% ;
PBMC-Monocyte : 0.79% ;
PBMC-B cells : 0.00% ;
PBMC-Erythroid Progenitors : 0.00% ;
Nipah henipavirus
PBMC-T cells : 2.86% ;
PBMC-B cells : 1.09% ;
PBMC-Macrophage : 0.51% ;
PBMC-Erythroid Progenitors : 0.00% ;
PBMC-Monocyte : 0.00% ;
Human mastadenovirus F
PBMC-T cells : 2.86% ;
PBMC-Macrophage : 1.90% ;
PBMC-Monocyte : 0.79% ;
PBMC-B cells : 0.00% ;
PBMC-Erythroid Progenitors : 0.00% ;
Human mastadenovirus E
PBMC-T cells : 2.86% ;
PBMC-Macrophage : 1.90% ;
PBMC-Monocyte : 0.79% ;
PBMC-B cells : 0.00% ;
PBMC-Platelets : 0.00% ;
Coxsackievirus B6
PBMC-T cells : 2.86% ;
PBMC-Macrophage : 1.90% ;
PBMC-Monocyte : 0.79% ;
PBMC-B cells : 0.00% ;
PBMC-Erythroid Progenitors : 0.00% ;
Hendra henipavirus
PBMC-T cells : 2.86% ;
PBMC-B cells : 1.09% ;
PBMC-Macrophage : 0.51% ;
PBMC-Erythroid Progenitors : 0.00% ;
PBMC-Monocyte : 0.00% ;
Coxsackievirus B5
PBMC-T cells : 2.86% ;
PBMC-Macrophage : 1.90% ;
PBMC-Monocyte : 0.79% ;
PBMC-Platelets : 0.00% ;
PBMC-Erythroid Progenitors : 0.00% ;
Coxsackievirus B4
PBMC-T cells : 2.86% ;
PBMC-Macrophage : 1.90% ;
PBMC-Monocyte : 0.79% ;
PBMC-Erythroid Progenitors : 0.00% ;
PBMC-Platelets : 0.00% ;
JC polyomavirus
PBMC-Platelets : 2.44% ;
PBMC-B cells : 2.17% ;
PBMC-Macrophage : 0.95% ;
PBMC-T cells : 0.00% ;
PBMC-Erythroid Progenitors : 0.00% ;
Rabies lyssavirus
PBMC-Platelets : 2.44% ;
PBMC-T cells : 1.43% ;
PBMC-B cells : 1.09% ;
PBMC-Macrophage : 0.06% ;
PBMC-Erythroid Progenitors : 0.00% ;
Bovine alphaherpesvirus 1
PBMC-B cells : 2.17% ;
PBMC-Macrophage : 1.08% ;
PBMC-T cells : 0.00% ;
PBMC-Erythroid Progenitors : 0.00% ;
PBMC-Monocyte : 0.00% ;
Hepatitis E virus
PBMC-B cells : 2.17% ;
PBMC-Platelets : 1.22% ;
PBMC-Macrophage : 0.06% ;
PBMC-T cells : 0.00% ;
PBMC-Erythroid Progenitors : 0.00% ;
Human alphaherpesvirus 2
PBMC-B cells : 2.17% ;
PBMC-Macrophage : 1.08% ;
PBMC-T cells : 0.00% ;
PBMC-Erythroid Progenitors : 0.00% ;
PBMC-Monocyte : 0.00% ;
Suid alphaherpesvirus 1
PBMC-B cells : 2.17% ;
PBMC-Macrophage : 1.08% ;
PBMC-T cells : 0.00% ;
PBMC-Monocyte : 0.00% ;
PBMC-Platelets : 0.00% ;
Ecotropic murine leukemia virus
PBMC-B cells : 2.17% ;
PBMC-Platelets : 1.22% ;
PBMC-Macrophage : 0.13% ;
PBMC-T cells : 0.00% ;
PBMC-Erythroid Progenitors : 0.00% ;
Jaagsiekte sheep retrovirus
PBMC-T cells : 1.43% ;
PBMC-Macrophage : 0.95% ;
PBMC-Monocyte : 0.79% ;
PBMC-B cells : 0.00% ;
PBMC-Erythroid Progenitors : 0.00% ;
Enterovirus D68
PBMC-B cells : 1.09% ;
PBMC-Macrophage : 0.32% ;
PBMC-T cells : 0.00% ;
PBMC-Platelets : 0.00% ;
PBMC-Erythroid Progenitors : 0.00% ;
Human betaherpesvirus 6B
PBMC-B cells : 1.09% ;
PBMC-Macrophage : 0.25% ;
PBMC-Erythroid Progenitors : 0.00% ;
PBMC-Monocyte : 0.00% ;
PBMC-Platelets : 0.00% ;

Contact Us

E-mail: chendongsheng@genomics.cn

Address: Build 11, Beishan Industrial Zone, Yantian District, Shenzhen, 518083, China

Copyright © VThunter 2020-2021 ShenZhen, Guangdong province, China